Mouse Cytomegalovirus infection overrules T regulatory cell suppression on natural killer cells
© Lindenberg et al.; licensee BioMed Central Ltd. 2014
Received: 4 April 2014
Accepted: 24 July 2014
Published: 9 August 2014
Cytomegalovirus establishes lifelong persistency in the host and leads to life threatening situations in immunocompromised patients. FoxP3+ T regulatory cells (Tregs) critically control and suppress innate and adaptive immune responses. However, their specific role during MCMV infection, especially pertaining to their interaction with NK cells, remains incompletely defined.
To understand the contribution of Tregs on NK cell function during acute MCMV infection, we infected Treg depleted and undepleted DEREG mice with WT MCMV and examined Treg and NK cell frequency, number, activation and effector function in vivo.
Our results reveal an increased frequency of activated Tregs within the CD4+ T cell population shortly after MCMV infection. Specific depletion of Tregs in DEREG mice under homeostatic conditions leads to an increase in NK cell number as well as to a higher activation status of these cells as compared with non-depleted controls. Interestingly, upon infection this effect on NK cells is completely neutralized in terms of cell frequency, CD69 expression and functionality with respect to IFN-γ production. Furthermore, composition of the NK cell population with regard to Ly49H expression remains unchanged. In contrast, absence of Tregs still boosts the general T cell response upon infection to a level comparable to the enhanced activation seen in uninfected mice. CD4+ T cells especially benefit from Treg depletion exhibiting a two-fold increase of CD69+ cells 40 h and IFN-γ+ cells 7 days p.i. while, MCMV infection per se induces robust CD8+ T cell activation which is also further augmented in Treg-depleted mice. Nevertheless, the viral burden in the liver and spleen remain unaltered upon Treg ablation during the course of infection.
Thus, MCMV infection abolishes Treg suppressing effects on NK cells whereas T cells benefit from their absence during acute infection. This study provides novel information in understanding the collaborative interaction between NK cells and Tregs during a viral infection and provides further knowledge that could be adopted in therapeutic setups to improve current treatment of organ transplant patients where modulation of Tregs is envisioned as a strategy to overcome transplant rejection.
KeywordsMouse cytomegalovirus Tregs NK cells
Mouse cytomegalovirus (MCMV) belongs to the family of β-herpes viruses and shares many attributes with human cytomegalovirus (HCMV). This makes it an attractive tool to study CMV associated immune responses in an infection model to better characterize the CMV-host relationship in vivo. CMV reactivation and primary infection pose as a major health concern in transplantation medicine leading to life threatening consequences in immunocompromised patients. As a means of suppressing transplant rejections in patients, one novel proposed strategy has been to adoptively transfer ex vivo expanded FoxP3+ T regulatory cells (Tregs) . In order to better understand their role in acute CMV infection, this study sets out to elucidate their interaction with NK cells and effector T cells using an MCMV mouse model. Natural Tregs are major players in suppressing the immune system and are therefore important for controlling the balance between activation and tolerance [2, 3]. The transcription factor FoxP3 is a specific regulatory gene that distinguishes Tregs from other cell types and is important for their suppressive function . A frameshift mutation in the FoxP3 gene locus on the X-chromosome in Scurfy mice results in a lethal multi-organ inflammation caused by a massive proliferation of effector T cells . Despite the fact that Tregs are crucial for maintenance of the immune homeostasis, they are also known to suppress the immune system in several diseased conditions like cancer  or in the context of infections for example induced by viruses [7–13]. In doing so, they dampen pathogen-specific innate or adaptive immune responses and impede pathogen clearance from the host in most infectious settings. Treg suppression spans a diverse cohort of immune cells including monocytes, dendritic cells (DCs), NK cells, NKT cells, CD4+ and CD8+ effector T cells [14, 15]. They conduct their suppression using an arsenal of mechanisms such as modulating the bioavailability of IL-2 [16, 17], production of certain cytokines like IL-10, IL-35, TGF-β and signaling molecules like cAMP , direct killing  or downregulating co-stimulatory molecules CD80/86 on DCs via CTLA-4 by trans-endocytosis  and thereby indirectly suppress T effector responses. During acute MCMV infection, NK cells predominantly confer resistance against MCMV-induced pathogenesis by recognizing the viral m157 glycoprotein on infected cells via the Ly49H receptor [21–23]. Thus, mouse strains exhibiting NK cells equipped with this receptor like C57BL/6 are far more resistant than strains lacking it like BALB/c. According to Dokun et al [24, 25], the NK response to MCMV constitutes three phases. The first phase consists of an unspecific proliferation of NK cells with no preferential expansion of the Ly49H+-MCMV specific subset, which is postulated to be mostly cytokine dependent, followed by an MCMV-specific expansion and subsequent outgrowth of Ly49H+ cells within the NK cell population. In contrast to other Ly49 receptors, Ly49H associates with immunoreceptor tyrosine-based activation motifs (ITAMs) on the adaptor molecules DAP10 and DAP12, which are responsible for inducing proliferation and activation [22, 26]. The final phase consists of a slow contraction of the total NK cell response and frequency until baseline levels are achieved [24, 27].
Studies carried out by Ghiringhelli et al., demonstrated that mutant Scurfy mice lacking the functional gene FoxP3 exhibited, in addition to highly activated T effector cells, a 10 fold greater NK cell proliferation . Furthermore, enhanced cytotoxicity of NK cells was observed as compared with WT mice with no added influence on their activation state. In vitro studies as well as tumor mouse models provided evidence that a direct control of Tregs on NK cells may exist and results in impaired functionality of NK cells in the presence of Tregs [28–30]. Membrane-bound Transforming growth factor beta was proposed to be involved in this process, since blocking antibodies of this complex abolished the observed effects . Recent studies by Gasteiger et al. showed an indirect interaction mediated by increased IL-2 levels produced by CD4+ T cells upon Treg depletion [31, 32]. IL-2 signaling on NK cells induced proliferation and additionally enhanced their cytotoxic function via increased sensitivity for target cells.
These observations led us to ask the question whether this interaction between NK cells and Tregs is also of importance in a viral model like MCMV, where NK cell proliferation is initially cytokine dependent and later driven by signaling of the NK cell-activating receptor Ly49H.
Here, we show that boosting effects of Treg depletion on NK cells under homeostatic conditions are overruled upon MCMV infection with no preferential effects on Ly49H subsets. The viral clearance remains unchanged even though we observe enhanced general T cell activation, highlighting the outstanding role of NK cells in controlling MCMV infection in C57BL/6 mice. These results clearly indicate that the role of Treg-mediated suppression on NK cells activated by MCMV infection is at best negligible, whereas the activation of T cells is further enhanced in the absence of Tregs.
MCMV infection leads to elevated FoxP3+ Tregs in the CD4+ T cell compartment
Depletion of Tregs enhances NK cell frequency, number and activation state under homeostatic conditions with no added influence upon MCMV infection
Interferon-γ production of NK cells in response to MCMV is not further enhanced in the absence of Tregs
Viral burden remains unaltered upon ablation of Tregs
Ablation of Tregs results in a boosted general T cell response
CMV is a medically important DNA virus with high pathogenesis in immunocompromised and newborn individuals, representing a major reason for organ rejection in transplanted patients. Although anti-viral therapies to treat CMV disease are employed in the clinics, treatment is associated with poor oral bioavailability, development of anti-viral drug resistance over time and anti-viral drug related cytotoxicities . Hence, there remains an urgent need to develop new anti-CMV compounds with different mechanism of action to reduce morbidity and contain infection. Thus, targeting Tregs has been suggested as a potential cell mediated approach for immunotherapy against infections .
A number of studies examining this concept, demonstrated the contribution of Tregs in promoting suppression of pathogen specific effector responses [7–10, 45–48], while others showed beneficial effects of Tregs upon infections [12, 49–52]. In this study, we set out to primarily examine the role of Tregs in modulating the MCMV-specific NK cell responses during the acute phase of infection, which until now remained incompletely defined. We observed elevated Treg frequencies among CD4+ T cells in the spleen early upon infection, indicating that MCMV infection may preferentially support differentiation of naïve T cells into Tregs, similarly described in a hepatitis virus infection model  where TGF-β induced by infection controlled this phenotypic change. To specifically address the question of whether the increase in Tregs influences the ongoing activation of innate and adaptive immune responses, we utilized DEREG mice to facilitate specific Treg depletion by Diphtheria toxin (DT) administration . The advantage of the rapid and efficient depletion of Tregs in our model provided us the opportunity to infect mice on the day of first DT injection to really assess the influence of Tregs on NK cells during virus replication and thus minimize effects occurring prior to the onset of infection. This fact could account for the contrasting results Sungur et al. reported in terms of enhanced viral clearance upon CD25 antibody-mediated Treg depletion starting 2 days before infection . In respect to these findings, we observed that under homeostatic conditions, depletion of Tregs significantly increased NK cell numbers and NK cell CD69 expression. Thus, depletion prior to infection could contribute to this discrepancy between both studies by conferring enhanced anti-viral defense already before infection. As Tregs return to baseline levels by day 7 p.i. in uninfected mice, our experimental mouse model avoids the development of artificial autoimmunity  and hence provides an unbiased approach to examine the phenotypes observed here upon infection. To further elucidate the interaction of Tregs with NK cells, and its influence on control of MCMV replication in C57BL/6 mice, we examined NK cell numbers and activation in the absence of Tregs. We detected elevated NK cell frequencies in uninfected DEREG mice depleted of Tregs consistent with findings reported in Scurfy mice and FoxP3 DTR knock-in mice [28, 32]. These cells additionally showed notably higher CD69 expression. In contrast, upon infection, we observed comparable NK cell responses between Treg-depleted and non-depleted mice. Studies by Fulton et al. and Lee et al. reported concordantly increased NK cell numbers in the lungs of Respiratory Syncytial Virus infected-BALB/c mice upon Treg depletion, which was carried out again by CD25 antibody administration starting already 3 days prior to infection [56, 57]. Using uninfected FoxP3 DTR knock-in mice, Gasteiger et al. pointed out that the increase of NK cell numbers upon Treg depletion corresponds to elevated CD127+ NK cell frequencies, expressing higher amounts of high affinity IL-2 receptor CD25 . Therefore, enhanced IL-2 production by effector CD4+ T cells in the absence of Tregs may represent the likely mechanism underlying this phenomenon. This hypothesis was further substantiated by experiments that showed abrogation of this effect by blocking the IL-2 pathway or depleting the CD4+ T cell compartment  and similarly reported by Sitrin et al. in an autoimmune diabetes mouse model . Our results in uninfected mice corroborate these findings as we similarly detected higher activation of CD4+ T cells upon Treg depletion. Although we observed a boosted CD4+ as well as CD8+ T cell response in DEREG MCMV + DT-treated mice as compared with WT MCMV + DT-treated mice, we could not detect differences in NK cell frequencies in infected mice suggesting that this proposed mechanism will need further clarification under a more infectious setting such as a salivary gland infection, where the demand for Ly49H+ NK cells would be further exemplified. A possible reason for this discrepancy could be that NK cells already achieve maximal proliferation upon tissue cultured MCMV infection and thus, fail to benefit from Treg depletion or elevated IL-2 levels. Treg depletion in MCMV-infected mice leads to higher proliferation of effector T cells, predominantly CD8+ T cells which represent the majority of T cells at day 7 p.i. Thus, consumption of IL-2 by proliferating CD8+ T cells which is not seen upon Treg depletion under homeostatic conditions, may offer another potential explanation. Treg ablation leads to similar frequencies of CD62low CD4+ T cells as compared with those induced by MCMV infection alone. However, CD8+ T cells are significantly more activated upon MCMV infection than upon Treg depletion of naive mice and thus could abrogate IL-2 mediated effects. The insensitivity of the viral clearance to a boosted T cell response highlighted the importance of NK cells in limiting WT MCMV replication in C57BL/6 mice emphasized by a rapid clearance until day 7. The implications of Treg control over effector CD8+ T cell response would prove critical if the Ly49H receptor engagement was somehow abrogated as observed in the case of mice challenged with Δm157-strain of MCMV, where CD8+ effector T cells critically governed the outcome of viral replication in infected organs . In Ly49H+ NK cell competent C57BL/6 mice, we observed an initial viral burden that was already 100-fold reduced and close to the detection limit when the T cell response peaked. Our findings provide further support to the multi-functional importance of NK cells spanning the innate and adaptive arms of the immune system [59–61]. Furthermore, since MCMV infection primarily induces stronger CD8+ T cell responses, the contribution of the enhanced CD4+ T cell activation we observe upon infection in Treg depleted mice would require further investigation. CD4+ T cells are key players in establishing immunological memory and moreover known to develop cytotoxic abilities to directly attack infected cells under certain circumstances [62–64]. This makes them an important factor during MCMV infection and their importance may be further enhanced upon their suppression by Tregs. Thus, our results provide new evidence that Tregs play a role in modulating the immune response to MCMV infection, but this effect seems to be restricted to the suppression of adaptive immune cell activation. Our results suggest that Tregs enhance the general effector T cell response while NK cell function remains unaltered. This expansion in the CD8 T cell pool would warrant for further investigation into the contribution of Treg depletion on the antigen-specific effector T cell compartment after infection. The importance of Treg regulation on CD8 T cells in the absence of Ly49H-NK cell recognition has been recently analyzed in an independent study described by us in collaboration with Hansen and colleagues, showing enhanced activation, cytotoxicity and improved viral clearance in DEREG Balb/c mice depleted of Tregs . Thereby, suggesting an important regulatory role by which NK-Ly49H function in concert with Tregs modulate anti-MCMV T cell effector responses . This could be further extended into infection models in C57BL/6 mice employing a Δm157 MCMV strain, where the requirement for antigen specific T cells in viral clearance is further exemplified. Overall, our findings provide a foundation for the development of future Treg-mediated therapeutics in viral infections and in a broader context, in Treg-modulating strategies to overcome transplant rejection.
Materials and methods
Previously described DEREG mice on C57BL/6 background were used, allowing for the efficient and selective depletion of FoxP3+ T regulatory cells by the administration of Diphtheria toxin (DT) . DT was administered in the amount of 25 ng/g bodyweight on both the day of infection and the following one. Male DEREG mice aged 8-12 weeks were used for experiments and gender- and aged-matched WT littermates served as controls. Mice were housed under specific pathogen free conditions at the animal facility of Twincore (Hannover, Germany). The protocol for this research study involving mice was approved by a suitably constituted Ethics Committee of the institution and was performed in accordance with animal welfare guidelines approved by institutional, state, and federal committees. Mice were sacrificed by CO2 asphyxiation in accordance with German animal welfare law. Every effort was made to minimize animal suffering.
For infection, BAC derived MCMV WT Smith strain was used , which was kindly provided by Martin Messerle (Institute of Virology, Hannover Medical School, Germany). Virus propagation was carried out on doxycycline induced murine embryonic fibroblasts, also kindly provided by Dr. Tobias May from the Helmholtz Center for Infection Research and InSCREENeX (Braunschweig, Germany) . Mice were infected with 106 pfu of tissue cultured-derived virus by the intraperitoneal route.
Viral titers were determined by plaque assay performed on mouse embryonic fibroblasts (MEFs) as previously described . Spleens and livers were frozen with 0.5 ml DMEM medium and after brief thawing homogenized using a TissueLyserLT (Qiagen) (50 Hz, 2:30 min). Ten-fold dilutions were prepared in duplicates and sub-confluent MEF layers were inoculated with homogenates for 2 h at 37°C. Following incubation, the inoculum was removed and cells were overlayed with 0.75% (w/v) carboxymethylcellulose (Sigma) in growth medium for each well. Plaques were counted after 6-8 days.
Red blood cells in single-cell suspensions of spleens were lysed using RBC lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA). The isolated cells were counted by Trypan Blue exclusion and adjusted to the same cell number for FACS staining. After washing with PBS, cells were stained with the LIVE/DEAD® Fixable Aqua Dead Cell Stain Kit (Invitrogen, Life Technologies GmbH, Darmstadt, Germany) to exclude dead cells. Following incubation with FACS buffer (0.25% BSA/ 2 mM EDTA in PBS) containing Fc-block (CD16/32, 2.4G2) for 10 min on ice cells were stained for surface markers with the following fluorochrome conjugated anti-mouse antibodies for 20 to 30 min on ice:
CD3 (145-2C11), CD4 (GK1.5), CD8α (53-6.7), CD25 (PC61.5), CD62L (MEL-14), CD69 (H1.2 F3), KLRG-1 (2 F1), Ly49H (3D10), NK1.1 (PK136).
Cells were fixed by using the Foxp3/Transcription Factor Staining Buffer Set (eBioscience, affymetrix, Frankfurt, Germany). Anti-mouse FoxP3 antibody FJK-16 s and anti-mouse CTLA-4 antibody UC10-4B9 (BioLegend, London, United Kingdom) were used for intracellular staining.
Unless otherwise stated, all antibodies were purchased from eBioscience, affymetrix (Frankfurt, Germany). Samples acquisition was performed on an LSRII Flow cytometer (BD Bioscience GmbH, Heidelberg, Germany), with the results analyzed using FlowJo software (Tree Star, Inc. Ashland, USA). Accurate gating was confirmed by single stains and fluorescence minus one controls, with non-specific binding was estimated by isotype controls. Cellular aggregates were excluded by SSC-W.
Ex vivo stimulation assays
NK cell production of Interferon- γ (IFN-γ) was assessed by IL-2 re-stimulation in a 96-well U bottom plate. Splenocytes in the amount of 3×106 were incubated with 250 U/ml IL-2 for 2 h initially, followed by an additional 2 h in the presence of 3 μg/ml BrefeldinA with 125 U/ml. For T cell ex vivo stimulation 25 ng/ml Phorbol-12-myristate-13-acetate (PMA) and 250 ng/ml Ionomycin were used for 4 h in the presence of 3 μg/ml BrefeldinA. Cells were stained for surface markers as described under Flow Cytometry. Intracellular staining for IFN-γ was performed after fixation in 2% PFA in PBS for 20 min on ice and permeabilization in PBS containing 0.25% BSA, 2 mM EDTA, and 0.5% saponin. PE conjugated anti-mouse IFN-γ antibody clone XMG1.2 (eBioscience, affymetrix, Frankfurt, Germany) was used.
Two-tailed, unpaired Student’s t-test was used to calculate the statistical significance of differences between means of groups or samples. A p-value <0.05 was considered significant, as indicated by asterisk signs: (*) for P < 0.05, (**) for P < 0.01 and (***) for P < 0.001.
Killer cell lectin-like receptor G1
FoxP3+ T regulatory cell.
We would like to acknowledge the Hannover Biomedical Research School (HBRS, DFG GSC108) and the “StrucMed” program for supporting ML. Additionally, we thank Prof. Dr. Martin Messerle, Dr. Kirsten Keyser and Karen Wagner for advice on the work with MCMV. Furthermore we express our acknowledgment to Dr. Tobias May for providing the Dox-MEF cell line. We are very thankful to Melanie Gohmert, Maike Hegemann, Friederike Kruse, Maxine Swallow and Martina Thiele for expert technical assistance and mouse management. For critical reading, we thank Aline Sandouk. Finally, we would like to acknowledge our funding source the Sonderforschungsbereich 900 (SFB-900) and the HiLF grant awarded by the Hannover Medical School for providing the resources for supporting this study.
- Schliesser U, Streitz M, Sawitzki B: Tregs: application for solid-organ transplantation. Curr Opin Organ Transplant 2012, 17: 34-41.PubMedView Article
- Berod L, Puttur F, Huehn J, Sparwasser T: Tregs in infection and vaccinology: heroes or traitors? Microb Biotechnol 2012, 5: 260-269.PubMedPubMed CentralView Article
- Mayer CT, Berod L, Sparwasser T: Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity. Front Immunol 2012, 3: 183.PubMedPubMed CentralView Article
- Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4: 330-336.PubMedView Article
- Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, Sparwasser T: Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 2007, 204: 57-63.PubMedPubMed CentralView Article
- Klages K, Mayer CT, Lahl K, Loddenkemper C, Teng MW, Ngiow SF, Smyth MJ, Hamann A, Huehn J, Sparwasser T: Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma. Cancer Res 2010, 70: 7788-7799.PubMedView Article
- Fernandez MA, Puttur FK, Wang YM, Howden W, Alexander SI, Jones CA: T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice. J Immunol 2008, 180: 1556-1564.PubMedView Article
- Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT: CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 2004, 172: 4123-4132.PubMedView Article
- Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT: CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 2003, 198: 889-901.PubMedPubMed CentralView Article
- Belkaid Y, Rouse BT: Natural regulatory T cells in infectious disease. Nat Immunol 2005, 6: 353-360.PubMedView Article
- Iwashiro M, Messer RJ, Peterson KE, Stromnes IM, Sugie T, Hasenkrug KJ: Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc Natl Acad Sci U S A 2001, 98: 9226-9230.PubMedPubMed CentralView Article
- Lund JM, Hsing L, Pham TT, Rudensky AY: Coordination of early protective immunity to viral infection by regulatory T cells. Science 2008, 320: 1220-1224.PubMedPubMed CentralView Article
- Zelinskyy G, Dietze K, Sparwasser T, Dittmer U: Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus. PLoS Pathog 2009, 5: e1000406.PubMedPubMed CentralView Article
- Ralainirina N, Poli A, Michel T, Poos L, Andres E, Hentges F, Zimmer J: Control of NK cell functions by CD4+CD25+ regulatory T cells. J Leukoc Biol 2007, 81: 144-153.PubMedView Article
- Schmidt A, Oberle N, Krammer PH: Molecular mechanisms of treg-mediated T cell suppression. Front Immunol 2012, 3: 51.PubMedPubMed Central
- Kastenmuller W, Gasteiger G, Subramanian N, Sparwasser T, Busch DH, Belkaid Y, Drexler I, Germain RN: Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J Immunol 2011, 187: 3186-3197.PubMedPubMed CentralView Article
- McNally A, Hill GR, Sparwasser T, Thomas R, Steptoe RJ: CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis. Proc Natl Acad Sci U S A 2011, 108: 7529-7534.PubMedPubMed CentralView Article
- Bodor J, Bopp T, Vaeth M, Klein M, Serfling E, Hunig T, Becker C, Schild H, Schmitt E: Cyclic AMP underpins suppression by regulatory T cells. Eur J Immunol 2012, 42: 1375-1384.PubMedView Article
- Josefowicz SZ, Lu LF, Rudensky AY: Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012, 30: 531-564.PubMedView Article
- Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, Baker J, Jeffery LE, Kaur S, Briggs Z, Hou TZ, Futter CE, Anderson G, Walker LS, Sansom DM: Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 2011, 332: 600-603.PubMedPubMed CentralView Article
- Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, Iizuka K, Furukawa H, Beckman DL, Pingel JT, Scalzo AA, Fremont DH, Yokoyama WM: Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A 2002, 99: 8826-8831.PubMedPubMed CentralView Article
- Orr MT, Sun JC, Hesslein DG, Arase H, Phillips JH, Takai T, Lanier LL: Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection. J Exp Med 2009, 206: 807-817.PubMedPubMed CentralView Article
- Scalzo AA, Corbett AJ, Rawlinson WD, Scott GM, Degli-Esposti MA: The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol Cell Biol 2007, 85: 46-54.PubMedView Article
- Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, Yokoyama WM: Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2001, 2: 951-956.PubMedView Article
- Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY, Caligiuri MA, Durbin JE, Biron CA: Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002, 169: 4279-4287.PubMedView Article
- Sjolin H, Robbins SH, Bessou G, Hidmark A, Tomasello E, Johansson M, Hall H, Charifi F, Karlsson Hedestam GB, Biron CA, Kärre K, Höglund P, Vivier E, Dalod M: DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. J Immunol 2006, 177: 2908-2916.PubMedView Article
- Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP: Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999, 17: 189-220.PubMedView Article
- Ghiringhelli F, Menard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L: CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 2005, 202: 1075-1085.PubMedPubMed CentralView Article
- Shimizu J, Yamazaki S, Sakaguchi S: Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999, 163: 5211-5218.PubMed
- Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI, Hayakawa Y: CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 2006, 176: 1582-1587.PubMedView Article
- Gasteiger G, Hemmers S, Bos PD, Sun JC, Rudensky AY: IL-2-dependent adaptive control of NK cell homeostasis. J Exp Med 2013, 210: 1179-1187.PubMedPubMed CentralView Article
- Gasteiger G, Hemmers S, Firth MA, Le Floc'h A, Huse M, Sun JC, Rudensky AY: IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells. J Exp Med 2013, 210: 1167-1178.PubMedPubMed CentralView Article
- Powers C, DeFilippis V, Malouli D, Fruh K: Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 2008, 325: 333-359.PubMed
- Noriega V, Redmann V, Gardner T, Tortorella D: Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 2012, 54: 140-151.PubMedView Article
- Snyder CM, Cho KS, Bonnett EL, Allan JE, Hill AB: Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog 2011, 7: e1002295.PubMedPubMed CentralView Article
- Torti N, Walton SM, Brocker T, Rulicke T, Oxenius A: Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog 2011, 7: e1002313.PubMedPubMed CentralView Article
- Lahl K, Mayer CT, Bopp T, Huehn J, Loddenkemper C, Eberl G, Wirnsberger G, Dornmair K, Geffers R, Schmitt E, Buer J, Sparwasser T: Nonfunctional regulatory T cells and defective control of Th2 cytokine production in natural scurfy mutant mice. J Immunol 2009, 183: 5662-5672.PubMedView Article
- Loh J, Chu DT, O'Guin AK, Yokoyama WM, Virgin HW: Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol 2005, 79: 661-667.PubMedPubMed CentralView Article
- Sumaria N, van Dommelen SL, Andoniou CE, Smyth MJ, Scalzo AA, Degli-Esposti MA: The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity. Immunol Cell Biol 2009, 87: 559-566.PubMedView Article
- Dorner BG, Smith HR, French AR, Kim S, Poursine-Laurent J, Beckman DL, Pingel JT, Kroczek RA, Yokoyama WM: Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection. J Immunol 2004, 172: 3119-3131.PubMedView Article
- Orange JS, Biron CA: An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 1996, 156: 1138-1142.PubMed
- Mitrovic M, Arapovic J, Jordan S, Fodil-Cornu N, Ebert S, Vidal SM, Krmpotic A, Reddehase MJ, Jonjic S: The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8(+) T-cell response. J Virol 2012, 86: 2165-2175.PubMedPubMed CentralView Article
- Fogel LA, Sun MM, Geurs TL, Carayannopoulos LN, French AR: Markers of nonselective and specific NK cell activation. J Immunol 2013, 190: 6269-6276.PubMedPubMed CentralView Article
- Ahmed A: Antiviral treatment of cytomegalovirus infection. Infect Disord Drug Targets 2011, 11: 475-503.PubMedView Article
- Cabrera G, Burzyn D, Mundinano J, Courreges MC, Camicia G, Lorenzo D, Costa H, Ross SR, Nepomnaschy I, Piazzon I: Early increases in superantigen-specific Foxp3+ regulatory T cells during mouse mammary tumor virus infection. J Virol 2008, 82: 7422-7431.PubMedPubMed CentralView Article
- Aandahl EM, Michaelsson J, Moretto WJ, Hecht FM, Nixon DF: Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004, 78: 2454-2459.PubMedPubMed CentralView Article
- Haeryfar SM, DiPaolo RJ, Tscharke DC, Bennink JR, Yewdell JW: Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities. J Immunol 2005, 174: 3344-3351.PubMedView Article
- Fernandez MA, Yu U, Zhang G, White R, Sparwasser T, Alexander SI, Jones CA: Treg depletion attenuates the severity of skin disease from ganglionic spread after HSV-2 flank infection. Virology 2013, 447: 9-20.PubMedView Article
- Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ: Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 2009, 119: 3266-3277.PubMedPubMed Central
- Haque A, Best SE, Amante FH, Mustafah S, Desbarrieres L, de Labastida F, Sparwasser T, Hill GR, Engwerda CR: CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog 2010, 6: e1001221.PubMedPubMed CentralView Article
- Rowe JH, Ertelt JM, Way SS: Foxp3(+) regulatory T cells, immune stimulation and host defence against infection. Immunology 2012, 136: 1-10.PubMedPubMed CentralView Article
- Baumgart M, Tompkins F, Leng J, Hesse M: Naturally occurring CD4+Foxp3+ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J Immunol 2006, 176: 5374-5387.PubMedView Article
- Dunham RM, Thapa M, Velazquez VM, Elrod EJ, Denning TL, Pulendran B, Grakoui A: Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid. J Immunol 2013, 190: 2009-2016.PubMedPubMed CentralView Article
- Sungur CM, Tang-Feldman YJ, Ames E, Alvarez M, Chen M, Longo DL, Pomeroy C, Murphy WJ: Murine natural killer cell licensing and regulation by T regulatory cells in viral responses. Proc Natl Acad Sci U S A 2013, 110: 7401-7406.PubMedPubMed CentralView Article
- Mayer CTGP, Kühl AA, Stüve P, Hegemann M, Berod L, Gershwin ME, Sparwasser T: Few Foxp3+ regulatory T cells are sufficient to protect adult mice from lethal autoimmunity. Eur J Immunol 2014. In press edition
- Fulton RB, Meyerholz DK, Varga SM: Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J Immunol 2010, 185: 2382-2392.PubMedPubMed CentralView Article
- Lee DC, Harker JA, Tregoning JS, Atabani SF, Johansson C, Schwarze J, Openshaw PJ: CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J Virol 2010, 84: 8790-8798.PubMedPubMed CentralView Article
- Sitrin J, Ring A, Garcia KC, Benoist C, Mathis D: Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2. J Exp Med 2013, 210: 1153-1165.PubMedPubMed CentralView Article
- Mitrovic M, Arapovic J, Traven L, Krmpotic A, Jonjic S: Innate immunity regulates adaptive immune response: lessons learned from studying the interplay between NK and CD8+ T cells during MCMV infection. Med Microbiol Immunol 2012, 201: 487-495.PubMedPubMed CentralView Article
- Andoniou CE, Andrews DM, Degli-Esposti MA: Natural killer cells in viral infection: more than just killers. Immunol Rev 2006, 214: 239-250.PubMedView Article
- Robbins SH, Bessou G, Cornillon A, Zucchini N, Rupp B, Ruzsics Z, Sacher T, Tomasello E, Vivier E, Koszinowski UH, Dalod M: Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog 2007, 3: e123.PubMedPubMed CentralView Article
- Arens R, Wang P, Sidney J, Loewendorf A, Sette A, Schoenberger SP, Peters B, Benedict CA: Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response. J Immunol 2008, 180: 6472-6476.PubMedPubMed CentralView Article
- Andoniou CE, van Dommelen SL, Voigt V, Andrews DM, Brizard G, Asselin-Paturel C, Delale T, Stacey KJ, Trinchieri G, Degli-Esposti MA: Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 2005, 6: 1011-1019.PubMedView Article
- Jeitziner SM, Walton SM, Torti N, Oxenius A: Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection. Eur J Immunol 2013, 43: 2886-2895.PubMedView Article
- Jost NH: Regulatory T cells and T cell-derived IL-10 interfere with effective anti-cytomegalovirus immune response. Immunol and Cell Biol 2014. In press edition
- Wagner M, Jonjic S, Koszinowski UH, Messerle M: Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J Virol 1999, 73: 7056-7060.PubMedPubMed Central
- May T, Hauser H, Wirth D: Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization. Nucleic Acids Res 2004, 32: 5529-5538.PubMedPubMed CentralView Article
- Brune W, Hengel H, Koszinowski UH: A mouse model for cytomegalovirus infection. Curr Protoc Immunol 2001, Chapter 19: Unit 19 17.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.